ciprofloxacin has been researched along with sanguinarine chloride in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bi, F; Hu, C; Liu, J; Ma, R; Ma, S; Semple, SJ; Venter, H; Zhang, F | 1 |
Chen, W; Gu, X; Guo, T; Ma, S; Song, D; Zhang, L; Zhang, N; Zhang, P | 1 |
2 other study(ies) available for ciprofloxacin and sanguinarine chloride
Article | Year |
---|---|
Novel 5-methyl-2-phenylphenanthridium derivatives as FtsZ-targeting antibacterial agents from structural simplification of natural product sanguinarine.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Benzophenanthridines; Binding Sites; Biological Products; Cytoskeletal Proteins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoquinolines; Microbial Sensitivity Tests; Molecular Dynamics Simulation; Phenanthridines; Protein Structure, Tertiary; Structure-Activity Relationship | 2018 |
Design, synthesis and evaluation of novel 9-arylalkyl-10-methylacridinium derivatives as highly potent FtsZ-targeting antibacterial agents.
Topics: Acridines; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cytoskeletal Proteins; Dose-Response Relationship, Drug; Drug Design; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2021 |